Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Friday, July 26, 2024.
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)
Strong Uptrend (+100) - CRNX is in a strong uptrend that is likely to continue. With short-term, intermediate, and long-term bullish momentum, CRNX continues to climb. Traders should protect gains and look for a change in score to suggest a slow down in momentum.
Is it time to buy, sell, or avoid CRNX?
MarketClub looks at technical strength and momentum to determine if the timing is right for CRNX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CRNX
The long-term trend has been UP since Sep 11th, 2023 at 22.490
The intermediate-term trend has been UP since Jul 9th, 2024 at 47.255
The short-term trend has been UP since Jul 23rd, 2024 at 54.800
Smart Scan Analysis for CRNX
Based on our trend formula, CRNX is rated as a +100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 54.240 | 55.060 | 53.200 | 54.335 | +0.995 |
| Prev. Close | Volume | Bid | Ask | Time |
| 53.340 | 419618 | 2024-07-26 15:59:53 |
| Year High | 42 | Year High Date | 2018-09-10 |
| Year Low | 19.23 | Year Low Date | 2018-07-18 |
| 52wk High | 55.78 | 52wk High Date | 2024-07-23 |
| 52wk Low | 15.76 | 52wk Low Date | 2023-09-08 |
| Average Volume | 1,031,351 | Shares Outstanding | 78,860 |
| Market Cap | 425M | Assets | 978,153,000M |
| Liabilities | 103,220,000M | P/E Ratio | -7.20140000 |
| Volatility | 75.6 |